// App-Quantinova.ai

122 : Secukinumab and solid organ cancer: are they mutually exclusive?

Researchers

Presenter

  • Muhammad K Nisar

Principal Investigators

  • N/A

Medical Centers

  • Rheumatology, Luton & Dunstable University Hospital, Luton, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Psoriatic arthritis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved